Viemed Healthcare, INC Form 4 insider transactions

Viemed Healthcare, Inc. President Michael Moore sold 50,090 common shares for $7.33 each, as part of a pre-arranged Rule 10b5-1 trading plan.

Viemed Healthcare's President, Michael Moore, filed an amended Form 4 to correct a previously reported beneficial ownership of common shares.

Viemed Healthcare, Inc. President Michael Moore completed a series of transactions in late June 2025, involving the exercise of stock options and the subsequent sale of 181,316 common shares.

Viemed Healthcare, Inc. Director Nitin Kaushal reported exercising stock options and simultaneously selling an equal number of common shares on June 30, 2025, reducing his direct beneficial ownership.

Viemed Healthcare, Inc. Director Nitin Kaushal executed a series of transactions, exercising stock options and subsequently selling the acquired common shares on June 26 and June 27, 2025.

Director Timothy Smokoff sold shares of Viemed Healthcare, Inc. on March 13 and 14, 2025.

Viemed Healthcare's Chief Operating Officer, William Todd Zehnder, reported the vesting of restricted stock units and phantom share units, resulting in both acquisition and disposition of shares.

Viemed Healthcare's Chief Financial Officer, Trae Fitzgerald, reported the vesting of restricted stock units and phantom share units, along with associated tax withholdings, on January 29, 2025.

Viemed Healthcare's General Counsel, Jeremy Trahan, reported the vesting and disposition of restricted stock units and phantom share units on January 29, 2025.

A Viemed Healthcare executive, Jerome Cambre, reported the vesting of restricted stock units and phantom share units, along with associated tax withholdings and share transactions.

Viemed Healthcare's Chief Medical Officer, William Frazier, reported the acquisition and disposal of common shares and derivative securities, including restricted stock units and phantom share units, on January 29, 2025.

Viemed Healthcare's CEO, Casey Hoyt, engaged in multiple stock transactions on January 29, 2025, involving the vesting of restricted stock units and phantom share units.

Viemed Healthcare's President, Michael Moore, reported the vesting of restricted stock units and phantom share units, resulting in both acquisition and disposition of common shares.

Viemed Healthcare's Chief Financial Officer, Trae Fitzgerald, amended a previous SEC filing to reflect the withholding of shares for tax obligations related to the vesting of restricted stock units.

Viemed Healthcare's President, Michael Moore, amended a previous SEC filing to reflect the withholding of shares for tax obligations related to the vesting of restricted stock units.

Viemed Healthcare's CEO, Casey Hoyt, amended a previous SEC filing to reflect the withholding of shares for tax obligations related to the vesting of restricted stock units.

Viemed Healthcare's Chief Operating Officer, William Todd Zehnder, amended a previous SEC filing to reflect the withholding of shares for tax obligations related to the vesting of restricted stock units.

A Viemed Healthcare Vice President of Sales, Jerome Cambre, reported the acquisition of shares through the vesting of restricted stock units and the subsequent withholding of shares for tax obligations.

Viemed Healthcare's General Counsel, Jeremy Trahan, reported multiple transactions involving common shares and restricted stock units on January 17, 2025 and January 21, 2025.

Viemed Healthcare's Chief Operating Officer, William Todd Zehnder, reported multiple transactions involving common shares and derivative securities, including the vesting of restricted stock units and phantom share units.

Viemed Healthcare's CEO, Casey Hoyt, reported multiple transactions involving common shares, restricted stock units, and phantom share units.

Viemed Healthcare's Vice President of Sales, Jerome Cambre, reported multiple transactions involving common shares and restricted stock units, including vesting and tax withholdings.

Viemed Healthcare's President, Michael Moore, reported multiple transactions involving common shares and derivative securities, including the vesting of restricted stock units and phantom share units.

Viemed Healthcare's Chief Financial Officer, Trae Fitzgerald, reported multiple transactions involving common shares and restricted stock units, including acquisitions and disposals, on January 17th, 18th and 21st, 2025.

A Viemed Healthcare director, Nitin Kaushal, exercised stock options and sold shares on November 25th and 26th, 2024.

A Viemed Healthcare director, Nitin Kaushal, exercised stock options and sold shares on November 19th and 20th, 2024.

Director Randy E. Dobbs exercised stock options and sold shares of Viemed Healthcare, Inc. on November 13, 2024.

A Viemed Healthcare director, Nitin Kaushal, exercised stock options and sold shares on November 11th and 13th, 2024.

Bruce D. Greenstein, a director of Viemed Healthcare, exercised options to acquire 10,719 common shares on August 25, 2024.

Director Sabrina Heltz reports the vesting of restricted stock units into common shares of Viemed Healthcare.